— Know what they know.
Not Investment Advice

AQST NASDAQ

Aquestive Therapeutics, Inc.
1W: -10.6% 1M: +1.9% 3M: +7.1% YTD: -34.4% 1Y: +77.0% 3Y: +101.4% 5Y: +23.3%
$4.12
-0.11 (-2.60%)
 
Weekly Expected Move ±10.5%
$3 $4 $4 $5 $5
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Alpha Radar Neutral · Power 46 · $409.1M mcap · 95M float · 1.83% daily turnover · Short 54% of daily vol

📊 Key Metrics

TTM
$50M
Revenue
-7.3% YoY
$-69M
Net Income
-27.1% YoY
$-44M
Free Cash Flow
+9.6% YoY
76.0%
Gross Margin
-29.1%
Op. Margin
-55.8%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE146.9%
ROA-52.6%
ROIC188.8%

Valuation

P/E-7.3
P/B-14.8
EV/EBITDA-9.8

Leverage

Debt/Equity-3.90
Current Ratio3.14
Interest Cov.-3.2x

Quality Scores

Piotroski F4/9
Altman Z-2.35
Beneish M-2.34

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms